Startseite>>Signaling Pathways>> Apoptosis>> Other Apoptosis>>Higenamine hydrochloride

Higenamine hydrochloride

Katalog-Nr.GC38237

Higenamin-Hydrochlorid (Norcolaurin-Hydrochlorid), ein β2-AR-Agonist, ist ein SchlÜsselbestandteil des chinesischen Krauts Aconitum, das in den orientalisch-asiatischen LÄndern zur Behandlung von Symptomen der Herzinsuffizienz verschrieben wird.

Products are for research use only. Not for human use. We do not sell to patients.

Higenamine hydrochloride Chemische Struktur

Cas No.: 11041-94-4

Größe Preis Lagerbestand Menge
100mg
52,00 $
Auf Lager

Tel:(909) 407-4943 Email: sales@glpbio.com

Kundenbewertungen

Basiert auf Kundenrezensionen.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Higenamine hydrochloride (Norcoclaurine hydrochloride), a β2-AR agonist, is a key component of the Chinese herb aconite root that prescribes for treating symptoms of heart failure in the oriental Asian countries. Higenamine hydrochloride (Norcoclaurine hydrochloride) has anti-apoptotic effects[1][2].

[1]. Wu MP, et al. Higenamine protects ischemia/reperfusion induced cardiac injury and myocyte apoptosis through activation of β2-AR/PI3K/AKT signaling pathway. Pharmacol Res. 2016 Feb;104:115-23. [2]. Lee SR, et al. Acute oral intake of a higenamine-based dietary supplement increases circulating free fatty acidsand energy expenditure in human subjects. Lipids Health Dis. 2013 Oct 21;12:148.

Bewertungen

Review for Higenamine hydrochloride

Average Rating: 5 ★★★★★ (Based on Reviews and 25 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Higenamine hydrochloride

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.